Company / Inventory
West Pharmaceutical Services Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$443.9M
FY2025
5-year range
$377.0M / $443.9M
FY2021-FY2025
Trend
+17.7%
vs FY2024
Sector context
#44 of 115
Health Care
What the data says
At $444M, West Pharmaceutical Services's inventory ranks #44 of 115 in the Health Care sector. Inventory has fluctuated over the past 10 years, ranging from $199M in FY2016 to $444M in FY2025.
Based on SEC 10-K filings.
$444M in FY2025 with a 5-year CAGR of +6.7%.
Improved from $435M to $444M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- +6.7%
- 10-Year CAGR
- -
Sector benchmark
#44 of 115 in Health CareTop 38% of 115This company $443.9M Sector average $1.4B
▼
-68.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.7%, indicating consistent growth.
- In FY2025, inventory increased 17.7% year-over-year.
- Ranks #44 out of 115 companies in the Health Care sector.
- Lowest inventory in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $443.9M | +17.7% |
| FY2024 | $377.0M | -13.3% |
| FY2023 | $434.7M | +4.8% |
| FY2022 | $414.8M | +9.6% |
| FY2021 | $378.4M | +17.8% |
| FY2020 | $321.3M | +36.3% |
| FY2019 | $235.7M | +9.9% |
| FY2018 | $214.5M | -0.3% |
| FY2017 | $215.2M | +8.0% |
| FY2016 | $199.3M | +10.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026